Literature DB >> 31846529

Ovarian germ cell tumour classification: views from the testis.

Daniel M Berney1, Sara Stoneham2, Rupali Arora3, Jonathan Shamash4, Michelle Lockley1.   

Abstract

The classification of ovarian germ cell tumours has remained unchanged for many years, while there have been considerable changes in the testicular classification. In recent years there has been concern about the overtreatment of clinical stage 1 testicular germ cell tumours with increasing use of surveillance for low-risk disease. We outline here the current classification of germ cell tumours of the ovary with particular regard to treatment and outcome and highlight some areas which may cause confusion, particularly pertaining to immature teratomas and mixed germ cell tumours. We suggest that some minor changes to the classification, evidenced by a recent retrospective series by some of the authors, may lead to less adjuvant chemotherapy for immature teratomas and may obviate the need for the grading of immature teratomas, by aligning with testicular experience in pure post-pubertal teratomas. Adoption of this will require retrospective and prospective re-evaluation, but may avoid long-term patient morbidity.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Immature teratoma; dysgerminoma; germ cell tumour; neuroepithelium; ovary

Mesh:

Year:  2020        PMID: 31846529     DOI: 10.1111/his.14016

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

Review 1.  The Association of Ovarian Teratoma and Anti-N-Methyl-D-Aspartate Receptor Encephalitis: An Updated Integrative Review.

Authors:  Cheng-Yang Wu; Jiann-Der Wu; Chien-Chin Chen
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

2.  Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis.

Authors:  Antonella Turla; Manuel Zamparini; Massimo Milione; Salvatore Grisanti; Vito Amoroso; Rebecca Pedersini; Deborah Cosentini; Alfredo Berruti
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-21       Impact factor: 6.055

3.  Inositol monophosphatase 2 promotes epithelial ovarian cancer cell proliferation and migration by regulating the AKT/mTOR signaling pathway.

Authors:  Tangnur Ablimit; Gulxan Tursun; Yuanyuan Zhang; Guzalnur Abduxkur; Gulgina Abdurexit; Guzalnur Abliz
Journal:  Exp Ther Med       Date:  2022-09-12       Impact factor: 2.751

Review 4.  An introduction to the WHO 5th edition 2022 classification of testicular tumours.

Authors:  Daniel M Berney; Ian Cree; Vishal Rao; Holger Moch; John R Srigley; Toyonori Tsuzuki; Mahul B Amin; Eva M Comperat; Arndt Hartmann; Santosh Menon; George J Netto; Mark A Rubin; Samra Turajlic; Maria R Raspollini; Satish K Tickoo
Journal:  Histopathology       Date:  2022-07-01       Impact factor: 7.778

Review 5.  Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.

Authors:  Asaf Maoz; Koji Matsuo; Marcia A Ciccone; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Cancers (Basel)       Date:  2020-05-29       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.